National Cancer Institute; Notice of Closed Meetings, 70537-70538 [2014-27937]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 228 / Wednesday, November 26, 2014 / Notices
28. Girldene Jackson, Philadelphia,
Pennsylvania, Court of Federal Claims
No: 14–0973V.
29. James Bergeron, Southgate,
Michigan, Court of Federal Claims No:
14–0974V.
30. Margaret Bannister, Jefferson City,
Missouri, Court of Federal Claims No:
14–0975V.
31. Jennifer Peabody Barr, Franklin,
Tennessee, Court of Federal Claims No:
14–0977V.
32. Harvard Davis, Fair Oaks,
California, Court of Federal Claims No:
14–0978V.
33. Linda Parker, Palatka, Florida,
Court of Federal Claims No: 14–0979V.
34. StellaMarie Liverance,
Germantown, Tennessee, Court of
Federal Claims No: 14–0980V.
35. Kim Finch, Germantown,
Tennessee, Court of Federal Claims No:
14–0981V.
36. Tesha Smith, Dallas, Texas, Court
of Federal Claims No: 14–0982V.
37. Virginia Shives, Rockford, Illinois,
Court of Federal Claims No: 14–0983V.
38. Gaena Maria Laney, Fayetteville,
Arkansas, Court of Federal Claims No:
14–0984V.
39. Vivian Reinard, Doylestown,
Pennsylvania, Court of Federal Claims
No: 14–0987V.
40. Paula Sims, Yonkers, New York,
Court of Federal Claims No: 14–0988V.
41. Tracy Czuprynski, Boston,
Massachusetts, Court of Federal Claims
No: 14–0990V.
42. Rochelle Beaver, Boston,
Massachusetts, Court of Federal Claims
No: 14–0991V.
43. Christina Lokay, King of Prussia,
Pennsylvania, Court of Federal Claims
No: 14–0993V.
44. Monica Chenowith on behalf of A.
N., Baraboo, Wisconsin, Court of
Federal Claims No: 14–0996V.
45. Shari Buetow, Baraboo,
Wisconsin, Court of Federal Claims No:
14–0998V.
46. Krista Kuntzelman and James
Kuntzelman on behalf of Emma
Kuntzelman, Tampa, Florida, Court of
Federal Claims No: 14–0999V.
47. Erin Quackenbush-Baker, Twin
Falls, Idaho, Court of Federal Claims
No: 14–1000V.
48. Vincent M. Cusimano, New
Orleans, Louisiana, Court of Federal
Claims No: 14–1003V.
49. Irwin Reich, Hicksville, New
York, Court of Federal Claims No: 14–
1004V.
50. Chelsey Atnip, Kaysville, Utah,
Court of Federal Claims No: 14–1006V.
51. Nona Jones, Selmer, Tennessee,
Court of Federal Claims No: 14–1007V.
52. William Moyer, Middlebrook,
Virginia, Court of Federal Claims No:
14–1008V.
VerDate Sep<11>2014
17:21 Nov 25, 2014
Jkt 235001
53. Isaac Bord and Elisa Pagano on
behalf of Alexander Bord, Rockaway,
New York, Court of Federal Claims No:
14–1009V.
54. Elizabeth Schandel, Farmingville,
New York, Court of Federal Claims No:
14–1010V.
55. Garry Rehn, Elk River, Minnesota,
Court of Federal Claims No: 14–1012V.
56. Catherine Smith, Sault Sainte
Marie, Michigan, Court of Federal
Claims No: 14–1013V.
57. Ann Marie Plastino on behalf of
Alfred Plastino, Chicago, Illinois, Court
of Federal Claims No: 14–1014V.
58. Bruce A. Ling, Jr., Bristol, Florida,
Court of Federal Claims No: 14–1017V.
59. John Summers, Longview,
Washington, Court of Federal Claims
No: 14–1018V.
60. Steven T. McGehee, Greensboro,
North Carolina, Court of Federal Claims
No: 14–1020V.
61. Christopher Purvis, New London,
Connecticut, Court of Federal Claims
No: 14–1025V.
62. Renee Leetta Hunter, Bowie,
Maryland, Court of Federal Claims No:
14–1026V.
63. Reuben Calixto and Sandra
Calixto on behalf of D. C., Chicago,
Illinois, Court of Federal Claims No: 14–
1029V.
64. Heather Cook, Baraboo,
Wisconsin, Court of Federal Claims No:
14–1030V.
65. Hannah Baiona, Marblehead,
Massachusetts, Court of Federal Claims
No: 14–1032V.
66. Christie Shine, Loma Linda,
California, Court of Federal Claims No:
14–1033V.
67. Angela Clark, Shelby, North
Carolina, Court of Federal Claims No:
14–1034V.
68. Razene Lewis, Bossier City,
Louisiana, Court of Federal Claims No:
14–1035V.
69. David Weber, Mason, Ohio, Court
of Federal Claims No: 14–1036V.
70. Barbara Verdick, Dallas, Texas,
Court of Federal Claims No: 14–1039V.
71. Roberta Livolsi, Boston,
Massachusetts, Court of Federal Claims
No: 14–1040V.
72. Christine Haley, Boston,
Massachusetts, Court of Federal Claims
No: 14–1041V.
73. Richard Florida, Washington,
Pennsylvania, Court of Federal Claims
No: 14–1044V.
74. Helen Forrest, Jacksonville,
Florida, Court of Federal Claims No: 14–
1046V.
75. Connie Graham on behalf of
Kaden Stuart, Duncan, Oklahoma, Court
of Federal Claims No: 14–1047V.
76. James Greenamyre on behalf of
Lacey J. Greenamyre, Middlebury,
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
70537
Vermont, Court of Federal Claims No:
14–1048V.
77. Amy Fogg, Lancaster, New
Hampshire, Court of Federal Claims No:
14–1050V.
78. Julie Hallquist, Washington,
District of Columbia, Court of Federal
Claims No: 14–1052V.
79. Bruce A. Pederson, St. Cloud,
Minnesota, Court of Federal Claims No:
14–1055V.
80. Amanda L. Isaacson, Milwaukee,
Wisconsin, Court of Federal Claims No:
14–1056V.
81. Gregory Simpson and Sandra
Simpson on behalf of H. S., Vienna,
Virginia, Court of Federal Claims No:
14–1057V.
82. Sebastion J. Robinson, Ruston,
Louisiana, Court of Federal Claims No:
14–1058V.
83. Valerie Dobbins, Greensboro,
North Carolina, Court of Federal Claims
No: 14–1059V.
84. John Lovelady, Boston,
Massachusetts, Court of Federal Claims
No: 14–1063V.
85. Marc Cosentino, Boston,
Massachusetts, Court of Federal Claims
No: 14–1064V.
86. Miranda Werner on behalf of
P.M.S., Louisville, Kentucky, Court of
Federal Claims No: 14–1065V.
[FR Doc. 2014–27987 Filed 11–25–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel
Quantitative Imaging for Evaluation of
Response to Cancer Therapies.
Date: January 29–30, 2015.
Time: 10:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\26NON1.SGM
26NON1
70538
Federal Register / Vol. 79, No. 228 / Wednesday, November 26, 2014 / Notices
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
1E030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W266, Bethesda, MD 20892–9750,
240–276–6385, lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel Omnibus
SEP–17.
Date: March 25, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, 7W124,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: David Ransom, Ph.D.,
Research Programs Review Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W124, Bethesda, MD 20892–9750,
240–276–6351 david.ransom@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: November 20, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–27937 Filed 11–25–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Center for Scientific Review Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
November 11, 2014, 02:00 p.m. to
November 11, 2014, 03:00 p.m.,
National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on October 16, 2014, 79 FR 200
Pg. 62166.
The meeting will be held on
December 9, 2014 instead of November
11, 2014. The meeting will start at 12:00
VerDate Sep<11>2014
17:21 Nov 25, 2014
Jkt 235001
p.m. and will end at 2:00 p.m. The
meeting location remains the same. The
meeting is closed to the public.
Dated: November 20, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–27936 Filed 11–25–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket Number DHS–2013–0052]
Environmental Planning and Historic
Preservation Program
Department of Homeland
Security.
ACTION: Notice of Final National
Environmental Policy Act Implementing
Procedures.
AGENCY:
The purpose of this notice is
to inform the public that the Department
of Homeland Security (DHS or the
Department) is issuing the final update
to its policy and procedures for
implementing the National
Environmental Policy Act of 1969
(NEPA) (42 U.S.C. 4321 et seq.), as
amended, and the Council on
Environmental Quality (CEQ)
regulations for implementing the
procedural provisions of NEPA (40 CFR
parts 1500–1508). The Department’s
NEPA procedures are contained in
Directive 023–01, Rev. 01 and
Instruction Manual 023–01–001–01,
Rev. 01, Implementation of the National
Environmental Policy Act (herein after
referred to as Directive and Instruction).
This notice also responds to the
comments received on the Department’s
draft updated procedures published on
June 5, 2014 (79 FR 32563).
DATES: The Directive and Instruction
will be effective on March 26, 2015.
FOR FURTHER INFORMATION CONTACT: A.
Marie Ecton, Senior Environmental
Specialist, Department of Homeland
Security, Telephone (202) 360–5661, or
Email a.marie.ecton@hq.dhs.gov.
SUPPLEMENTARY INFORMATION: Once
effective, the Directive and Instruction
will apply to all of DHS, which is
currently comprised of over 20 support
and operational components, and help
ensure the integration of environmental
stewardship into DHS decision making
as required by NEPA. The Directive and
Instruction will serve as the DHS
implementing procedures for NEPA and
the CEQ regulations (as required by 40
CFR 1505.1 and 1507.3) and therefore
must be read in conjunction with the
CEQ regulations.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
The Directive and Instruction were
substantially revised to address a
number of circumstances and
requirements that have arisen since
April 19, 2006, the effective date of the
original DHS NEPA procedures (Federal
Register, Vol. 71, No. 64, April 4, 2006).
For example, when originally published
in 2006 the Directive and Instruction
did not apply to the following three
Components of DHS: Federal Emergency
Management Agency (FEMA), Customs
and Border Protection (CBP), and
United States Coast Guard (USCG);
these three Components each
maintained their own procedures for
implementing NEPA when the
Department was established in 2002.
This revision to the Directive and
Instruction incorporates FEMA, CBP,
and USCG into the Department’s NEPA
procedures and addresses the full scope
of DHS activities to which NEPA
applies. When the updated procedures
become effective, they will apply to all
Components of DHS, including FEMA,
CBP, and USCG. In addition, every
Component will have the option of
developing Supplemental Instructions
to establish how that particular
Component will meet the requirements
of the final version of the DHS Directive
and Instruction. In a separate yet related
effort, FEMA will pursue rescission of
its regulations at 44 CFR 10 and replace
them with Supplemental Instructions
that conform to requirements of the DHS
Directive and Instruction.
The requirements put forth in the
revised Directive and Instruction
emphasize that the NEPA process must
be appropriately integrated into the
performance of DHS missions and
activities and decision making. The
revised Directive establishes the overall
policy that DHS will comply with
NEPA, and the revised Instruction
establishes the procedures for ensuring
this compliance is implemented in an
effective and efficient manner. The
Instruction covers the following:
Overview of NEPA requirements,
including requirements for the
preparation and content of NEPA
documents; management of NEPA
implementation in DHS; criteria for
Components to obtain a delegation of
authority to approve their respective
NEPA reviews; public involvement;
dispute resolution; information
protected from public disclosure;
procedures for emergencies; review of
applications from persons or
organizations outside of DHS (e.g., grant
applications); and an identification of
the types of DHS activities normally
reviewed in a CATEX, Environmental
E:\FR\FM\26NON1.SGM
26NON1
]]>Agencies
[Federal Register Volume 79, Number 228 (Wednesday, November 26, 2014)]
[Notices]
[Pages 70537-70538]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27937]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel Quantitative Imaging for Evaluation of Response to Cancer
Therapies.
Date: January 29-30, 2015.
Time: 10:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 70538]]
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 1E030, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W266, Bethesda, MD 20892-9750, 240-276-6385,
lovingeg@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel Omnibus SEP-17.
Date: March 25, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, 7W124, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: David Ransom, Ph.D., Research Programs Review
Branch, Division of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive, Room 7W124, Bethesda, MD
20892-9750, 240-276-6351 david.ransom@nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: November 20, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-27937 Filed 11-25-14; 8:45 am]
BILLING CODE 4140-01-P
